Pfizer pouring COVID profits into cancer battle, CEO Bourla says
The COVID products drove Pfizer's revenue to record levels, topping $100 billion in 2022 and $80 billion in 2021.
People pose with syringe with needle in front of displayed Pfizer logo in this illustration taken.Updated: